Showing results (701-710 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|November 29, 2015
Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative cohort study
The Lancet. HIV|November 25, 2017
Economic incentives for HIV testing by adolescents in Zimbabwe: a randomised controlled trialKatharina Kranzer, Victoria Simms, Tsitsi Bandason, et al.
The Lancet. HIV|September 19, 2017
Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case reportElske Hoornenborg, Maria Prins, Roel C A Achterbergh, et al.
The Lancet. HIV|October 3, 2017
New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance dataLara Tavoschi, Joana Gomes Dias, Anastasia Pharris, et al.
The Lancet. HIV|February 25, 2018
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trialAlan Winston, Frank A Post, Edwin DeJesus, et al.
The Lancet. HIV|January 14, 2018
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trialPatrick Mercié, Julie Arsandaux, Christine Katlama, et al.
The Lancet. HIV|December 12, 2018
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trialSharon Nachman, Carmelita Alvero, Hedy Teppler, et al.
The Lancet. HIV|December 26, 2018
Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communitiesChama Mulubwa, Bernadette Hensen, Mwelwa M Phiri, et al.
The Lancet. HIV|March 16, 2018
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDSSherrie L Kelly, Rowan Martin-Hughes, Robyn M Stuart, et al.
The Lancet. HIV|March 30, 2018
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trialJean-Michel Molina, Kathleen Squires, Paul E Sax, et al.
Pageof 79